> top > docs > PMC:7172841 > spans > 33769-33966 > annotations

PMC:7172841 / 33769-33966 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T238 188-196 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T309 168-173 http://purl.obolibrary.org/obo/CLO_0007225 denotes label

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T282 168-173 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T265 0-197 Sentence denotes Six patients with immune dysregulation were treated with single intravenous infusion of 8 mg/kg of Tocilizumab (RoAcremra, Roche) based on the National Health Care off-label provision for COVID-19.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T98 18-38 Phenotype denotes immune dysregulation http://purl.obolibrary.org/obo/HP_0002958

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T942 18-24 UBERON:0002405 denotes immune
T943 25-38 GO:0065007 denotes dysregulation
T944 99-110 DG_35 denotes Tocilizumab
T945 188-196 SP_7 denotes COVID-19
T31044 18-24 UBERON:0002405;GO:0006955 denotes immune
T46550 25-38 GO:0006955 denotes dysregulation
T8807 18-24 UBERON:0002405 denotes immune
T62677 25-38 GO:0065007 denotes dysregulation
T41838 99-110 DG_35 denotes Tocilizumab
T58306 188-196 SP_7 denotes COVID-19

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1198 4-12 Species denotes patients Tax:9606
1199 99-110 Chemical denotes Tocilizumab MESH:C502936
1201 188-196 Disease denotes COVID-19 MESH:C000657245